|
"a fish, a barrel, and a smoking gun" |
|
|
Hit & Run XCVI
If ads aren't news, changes in advertising sure are, especially when the changes being considered affect advertisers' ability to deliver the product mnemonics we've come to accept as a reliable substitute for information on what the thing actually does. We've never been able to figure the fuss over prescription medication advertising's context-free cryptic evocations of brand names - why should they be any different from equally oblique ads for Heineken, Yahoo, or CK One? Still, the FDA's decision to allow drug advertisers the same freedom to misinform that other pitchmen have been loath to embrace anyway will be welcome news to some, namely, kids, who are - as we've repeatedly held - stupid, and need to be walked through a drug's benefits (like, will it make them look cool or feel invincible?) in order to be enticed to use it. Indeed, on Sunday, The New York Times reported that antidepressants were selling strong to the youthful set without the benefits of advertising or FDA approval. With that head start, we imagine campaigns aimed at youngsters ("We're the new generation, Gen-Effexor," and Prozac's more controversial "Screw Depression.") could have selective serotonin re-uptake inhibitors surpassing benzoil
peroxide adolescents use to smooth over teenage lumps. Of course, kids have been using various other
substances some time, and their market share will be tough one to, er, crack. One doctor observed that treating depression with legal medicine can keep kids from medicating themselves with illegal "feel-good drugs," (and legalizing theft will bring the crime rate down), but in order for the dummy pill to overtake the dummy pipe, it'll need something more than a snappy slogan and an Rx sheet. We understand that Joe Camel is free. (For now.) The September issue of Vanity Fair finally "outed" New York City Mayor Rudolph Giuliani's long-standing affair with underling Christyne Lategano. Such a nonrevelation seems unlikely to affect Giuliani's pretty unstoppable bid for reelection, but it was amusing to see The Wall Street Journal leap to his defense on its editorial page. Editor Robert L. Bartley also used the editorial to lambast VF once again for its August report on Dow Jones Chairman Peter Kann. "Vanity Fair's advertisers - Calvin Klein, Gucci, Ralph Lauren - presumably do not care whether the copy separating their messages is true or false, fair or foul. Their collective message seems to be that with the right gown/shoes/scents, you too can be decadent." Strong stuff from a publication that no doubt salivates over every lame-ass fashion IPO that comes down the pike. Graydon Carter seems unfazed by L'Affaire Dry Hump, however, and good for him. Now if he can show the same strength of purpose to the Canadians.... Determined to observe tomorrow's 50th birthday of our favorite nuclear-armed nation, but lacking the resources for anything like the New Yorker's bloated all-India issue, we've been scanning the headlines for good news. Unfortunately, as is often the case in the subcontinent, the news is mostly bad. Tuesday's assassination of film producer and music-industry tycoon Gulshan Kumar not only brings back bad memories of other music-related murders (and to this day, has anybody figured out how Suge didn't get hit even once?) but bodes ill for the world's largest movie industry. Along with the shooting earlier this year of filmmaker Mukesh Duggal and attempts on the lives of noted producers Rajiv Rai and Subhash Ghai, Kumar's assassination indicates the Indian film business is growing too dependent on dirty money. Deputy Chief Minister Gopinath Munde is urging the government to subsidize the movie business, and we've seen enough Amitabh Bachhan movies to know that the Hindi Stallone could crack this case wide open in under 90 minutes. Meanwhile, Hollywood now has two lessons to learn from Bollywood: 1) More musical
numbers with fuckups. courtesy of the Sucksters |
|
|
||
|
|
||
|
|
|
|
![]() The Sucksters |
![]() |